{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-067790","form_type":"8-K","ticker":"ORKA","cik":"0000907654","company_name":"Oruka Therapeutics, Inc.","filed_at":"2023-12-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.354235+00:00","generated_at":"2026-06-07T19:06:50.343871+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"ARCA biopharma increases retention bonuses for two execs by 50% to $150,000 each","bullets":["Retention bonus for Thomas Keuer and C. Jeffrey Dekker increased 50% to $150,000 each.","Early payment of $35,000 on Dec 8, 2023, to assist with tax obligations on RSU vesting.","Remaining $115,000 payable upon corporate transaction or board approval of clinical decisions.","Eligibility requires continued employment in good standing through payment event dates."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-067790","json":"https://secwatch.observer/filing/0000950170-23-067790.json","markdown":"https://secwatch.observer/filing/0000950170-23-067790.md","text":"https://secwatch.observer/filing/0000950170-23-067790.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/907654/000095017023067790/0000950170-23-067790-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/907654/000095017023067790/abio-20231129.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T19:06:50.343871+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}